SAYANA

This brand name is authorized in Austria, Brazil, Ecuador, Israel, Mexico, Netherlands, Romania, UK.

Active ingredients

The drug SAYANA contains one active pharmaceutical ingredient (API):

1	Medroxyprogesterone UNII C2QI4IOI2G - MEDROXYPROGESTERONE ACETATE
	Medroxyprogesterone acetate exerts anti-oestrogenic, anti-androgenic and antigonadotrophic effects.
	Read more about Medroxyprogesterone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
SAYANA Suspension for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G03AC06	Medroxyprogesterone	G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03A Hormonal contraceptives for systemic use → G03AC Progestogens
Discover more medicines within G03AC06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522718060081503
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	4506-MEE-1218
GB	Medicines & Healthcare Products Regulatory Agency	222089
IL	מִשְׂרַד הַבְּרִיאוּת	6581
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	473M2015
NL	Z-Index G-Standaard, PRK	90344
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W65275001, W65275002